Warning Letter Lays Out CAPA, Complaint Violations at Kit Company
First Medical Source, a Laguna Beach, Calif., company that assembles pain management kits and distributes infusion supplies, has been warned for design control failures and other quality system violations.
First Medical’s corrective and preventive action (CAPA) procedures were found wanting, according to the Sept. 26 letter posted recently online.
A series of infusion pump leaks were investigated and noted as corrected, but the company did not maintain records validating the corrections. Its response to this observation in the post-inspection Form 483 was found inadequate because it did not document the verification or validation of corrective design changes, or a retrospective review of other verification and validation actions. In addition, the company’s CAPA records were missing details about investigations and follow-up.
Don’t find yourself hurting from an incorrect CAPA investigation. What would you give if only you could pick the brain of someone who is coping successfully with CAPAs — the best and brightest, an industry leader.
Come for this valuable opportunity to hear FDA officials discuss regulatory plans and objectives — and ask questions you need answered; learn from device industry experts, consultants and other experts with actionable tips and strategies you can take straight back to the office; and network with other professionals who understand your challenges; share war stories and insights over a drink. Register Today.Read More
The FDA's new enforcement plan makes one thing clear: Developing a successful CAPA program has never been more important. But creating an FDA-proof CAPA isn’t easy. If only you could pick the brain of someone who is coping successfully with CAPA — the best and the brightest, an industry leader who has devised programs, procedures and solutions that have put companies out in front with the FDA. Well, you can. Register today.Read More
The FDA’s cadre of freshly trained inspectors — many of whom come directly from industry — and increased focus on specialized inspections are making it harder than ever to predict the outcome of your next FDA inspection. Unless, of course, you have Surviving an FDA Inspection at your fingertips. If you could spend less than $400 to get your drug manufacturing facility fully prepared to face a tough inspection by the FDA, would you even hesitate? ... Of course not!